Login

CEO Fernando Lehner Discusses BVZ Holding AG's 2017 Annual Results: An Interview | Fernando Lehner - CEO of bvz holding ag 00:10:00

Share On Facebook Share On Twitter

Fernando Lehner is the CEO of bvz holding ag

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
The worlds largest portfolio of marketplace startups|Fabrice Grinda,Founding Partner,FJ Labs
00:10:00
Lessons from a Hedge Fund Pioneer: Insights from Paul Marshall | Co-Founder and Chairman, Marshall Wace
00:10:00
Yes VC backs great companies at the early stages|Caterina Fake,Partner & Investor,Yes VC
00:10:00
The Right Value and the Right Clients with Guest Jason Speciner | JASON SPECINER - DIRECTOR OF INVESTMENT AND TAX PLANNING, FOUNDER
00:10:00
Rafaela Resources: Developing Critical Metals Projects in Spain and Canada
00:00:00
Practicing cardiologist at the Brigham and Women’s Hospital / Stanley Y. Shaw, MD, PhD Associate Dean for Executive Education
00:10:00
Revival Gold Expands High-Grade Resource at Beartrack-Arnett
00:10:00
"Unveiling Excellence: The Strategic Vision and Expertise of Permal - A Legg Mason Company"
00:00:00
Stéphane Boissel, CEO, Txcell SATXCL:PAR
00:10:00
Decoding Drill Results: A Guide by Top Geologists in Junior Mining | JEAN-PAUL TSOTSOS, CEO of Chesapeake Gold Corporation
00:10:00
HHS Provider Relief Fund: Extended Deadline for Dentists | Sharon K. Weaver, President, Mission Financial Planning.
00:10:00
Kootenay Silver at One-to-One Mining Conference: Company Overview and Strategic Focus on High-Grade Silver Projects in Mexico

© 2017 - Neuhu+